In8bio Inc Stock Investor Sentiment

INAB Stock  USD 0.23  0.02  8.00%   
About 64% of all In8bio's investors are looking to take a long position. The analysis of the overall investor sentiment regarding In8bio Inc suggests that some traders are interested. The current market sentiment, together with In8bio's historical and current headlines, can help investors time the market. In addition, many technical investors use In8bio Inc stock news signals to limit their universe of possible portfolio assets.

Comfort Level 64

 Interested

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use In8bio's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward In8bio Inc.

In8bio Historical Sentiment

Although In8bio's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding In8bio, such as negative comments on social media and news outlets, may cause fear in the market and push In8bio's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of In8bio.
  

In8bio Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards In8bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
2 days ago at news.google.com         
INAB stock touches 52-week low at 0.22 amid sharp annual decline - Investing.com India
Google News at Macroaxis
3 days ago at gurufocus.com         
IN8bio Inc Reports Q4 2024 EPS of -0.08, Aligns with Estimates Revenue Remains at 0 Million
Gurufocus Stories at Macroaxis
over a week ago at www.macroaxis.com         
Acquisition by Kreis Leslie W. of 574241 shares of In8bio at 1.5 subject to Rule 16b-3
Macroaxis News
over a week ago at finance.yahoo.com         
IN8bio Announces Advanced Gamma-Delta T cell Engager Platform for Oncology and Autoimmune Diseases
Yahoo News
over a week ago at gurufocus.com         
IN8bio Announces Advanced Gamma-Delta T cell Engager Platform for Oncology and ...
Gurufocus Stories at Macroaxis
over two weeks ago at thelincolnianonline.com         
IN8bio, Inc. Short Interest Up 768.0 percent in February
news
over two weeks ago at news.google.com         
Can IN8bios Gamma-Delta T Cell Therapies Disrupt Cancer Treatment CEO to Reveal Strategy Next Week -...
Google News at Macroaxis
over two weeks ago at gurufocus.com         
IN8bio to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
Gurufocus Stories at Macroaxis
over three weeks ago at finance.yahoo.com         
INAB Continued Survival in INB-100 Trial
Yahoo News
over three weeks ago at thelincolnianonline.com         
Short Interest in IN8bio, Inc. Decreases By 51.9
news
over three weeks ago at gurufocus.com         
Alyeska Investment Group, L.P. Acquires Additional Shares in IN8bio Inc
Gurufocus Stories at Macroaxis
over three weeks ago at thelincolnianonline.com         
IN8bio, Inc. Reports Positive Results from Ongoing Phase 1 Trial of INB-100 in Leukemia Patients New...
news
over three weeks ago at gurufocus.com         
IN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in ...
Gurufocus Stories at Macroaxis
over a month ago at news.google.com         
IN8bios INB-100 Shows Promising Results in AML Treatment, Analyst Recommends Buy with 8 Price Target...
Google News at Macroaxis
over a month ago at gurufocus.com         
IN8bio Reports Updated Positive Results from Phase 1 Trial of INB-100 in Leukemia Patients
Gurufocus Stories at Macroaxis
Far too much social signal, news, headlines, and media speculation about In8bio that are available to investors today. That information is available publicly through In8bio media outlets and privately through word of mouth or via In8bio internal channels. However, regardless of the origin, that massive amount of In8bio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of In8bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of In8bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to In8bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive In8bio alpha.

In8bio Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by William Ho of 1188282 shares of In8bio at 0.24 subject to Rule 16b-3
12/19/2024
2
Acquisition by Epperly Corinne of 37655 shares of In8bio at 0.24 subject to Rule 16b-3
12/23/2024
3
Acquisition by Brandt Peter C. of 33650 shares of In8bio at 1.47 subject to Rule 16b-3
01/24/2025
4
Acquisition by William Ho of 912450 shares of In8bio at 0.29 subject to Rule 16b-3
02/05/2025
5
IN8bio, Inc. Reports Positive Results from Ongoing Phase 1 Trial of INB-100 in Leukemia Patients New York, February 11, 2025 IN8bio, Inc. recently disclosed upd...
02/14/2025
6
Can IN8bios Gamma-Delta T Cell Therapies Disrupt Cancer Treatment CEO to Reveal Strategy Next Week - StockTitan
02/26/2025
7
IN8bio Announces Advanced Gamma-Delta T cell Engager Platform for Oncology and ...
03/03/2025
8
Acquisition by Kreis Leslie W. of 574241 shares of In8bio at 1.5 subject to Rule 16b-3
03/07/2025
9
INAB stock touches 52-week low at 0.22 amid sharp annual decline - Investing.com India
03/14/2025

Complementary Tools for In8bio Stock analysis

When running In8bio's price analysis, check to measure In8bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy In8bio is operating at the current time. Most of In8bio's value examination focuses on studying past and present price action to predict the probability of In8bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move In8bio's price. Additionally, you may evaluate how the addition of In8bio to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk